NorthWest Biotherapeutics Inc (NWBO)

[Rkmatters]

Steppen, The patients will not be done the treatment until sometime next month in May (last patient enrolled was in August, so May is last treatment). That was made clear at Oppenheimher, back in December. What she said was that they would share up-to-date patient information. That has not changed. The trial will still need to reach it's Phase I trial endpoint sometime in May, and so, yes, results could be in June (prior to 6/20 Spring/post summer). My expectation is July/August, because they will still need time for the May injection patient to age, assuming that patient remains enrolled and is alive and receives their final treatment.

First of all let me remind you that this trial is still on-going.  Most of the patients were enrolled between March and June.  And, we actually over enrolled the trial. The trial exceeded its maximum.  So we had some other patients enrolled in July and August.  But once the patient enrolled it takes about a month for them to go through the blood draw, have the one week product manufacturing, and get scheduled for their injections to start. So call it a month of preparation, and then it's an eight month treatment regimen. Right, so you can do the math. The patients who were the last ones in, who came in June and July will be finishing their treatment regimen in March and April. --LP at Oppenheimher

Since they enrolled patient(s) in August, you need to tag on a month to July enrollment/April finish, and that's how you get to May.